Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP803501.RAqS-bs8VUuONqQ8C4mUB9o0GPRm88P-UwVw5muv5LnvU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP803501.RAqS-bs8VUuONqQ8C4mUB9o0GPRm88P-UwVw5muv5LnvU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP803501.RAqS-bs8VUuONqQ8C4mUB9o0GPRm88P-UwVw5muv5LnvU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP803501.RAqS-bs8VUuONqQ8C4mUB9o0GPRm88P-UwVw5muv5LnvU130_provenance.
- NP803501.RAqS-bs8VUuONqQ8C4mUB9o0GPRm88P-UwVw5muv5LnvU130_assertion description "[Vascular endothelial growth factor (VEGF), basic fibroblastic growth factor (FGF2), and transforming growth factor-beta1, beta2, beta3 (TGF-beta1, 2, 3) and cognate receptors (TGF-betaRI, II, III) mRNA expression pattern was evaluated by RT-PCR in 25 breast cancer tissue samples and adjacent normal tissues, and correlated to clinicopathological features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803501.RAqS-bs8VUuONqQ8C4mUB9o0GPRm88P-UwVw5muv5LnvU130_provenance.
- NP803501.RAqS-bs8VUuONqQ8C4mUB9o0GPRm88P-UwVw5muv5LnvU130_assertion evidence source_evidence_literature NP803501.RAqS-bs8VUuONqQ8C4mUB9o0GPRm88P-UwVw5muv5LnvU130_provenance.
- NP803501.RAqS-bs8VUuONqQ8C4mUB9o0GPRm88P-UwVw5muv5LnvU130_assertion SIO_000772 15949894 NP803501.RAqS-bs8VUuONqQ8C4mUB9o0GPRm88P-UwVw5muv5LnvU130_provenance.
- NP803501.RAqS-bs8VUuONqQ8C4mUB9o0GPRm88P-UwVw5muv5LnvU130_assertion wasDerivedFrom befree-20140225 NP803501.RAqS-bs8VUuONqQ8C4mUB9o0GPRm88P-UwVw5muv5LnvU130_provenance.
- NP803501.RAqS-bs8VUuONqQ8C4mUB9o0GPRm88P-UwVw5muv5LnvU130_assertion wasGeneratedBy ECO_0000203 NP803501.RAqS-bs8VUuONqQ8C4mUB9o0GPRm88P-UwVw5muv5LnvU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP803501.RAqS-bs8VUuONqQ8C4mUB9o0GPRm88P-UwVw5muv5LnvU130_provenance.